Abstract
The effects of the water-soluble and delayed-release formulations of a nonsteroidal antiinflammatory drug, diclofenac, on the healing of gastroduodenal mucosal lesions were compared in a double-blind, double cross-over, placebo-controlled endoscopic study conducted in 14 healthy volunteers. Severe endoscopic lesions (petechiae, erosions, ulcers, and esophageal candidiasis) were found only in the group taking the soluble formulation of diclofenac (P<0.05 vs placebo). The endoscopic healing of biopsies at one week was delayed by both preparations in comparison to placebo (P<0.05 vs placebo). Neither formulation produced significantly more histological inflammation or minor endoscopic lesions (erythema, red striae) than placebo. Both formulations were equally well tolerated and produced no more symptoms than placebo. This study suggests that soluble diclofenac acts topically to delay gastroduodenal healing and produce gastroduodenal injury; it thus provides a model for future studies of the production, perpetuation, and healing of peptic lesions.
Similar content being viewed by others
References
La toxicité gastro-intestinale relative des AINS, une analyse de l'incidence.In Rhuma-thérapie actuel, G Gallachi (ed) No. 2, Editions Eular, Basle, 1988, pp 14-15
Lanza FL, Royer GL, Nelson RS: Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 303:136–138, 1980
Caruso M, Bianchi Porro G: Gastrocopic evaluation of antiinflammatory agents. Br Med J 1:75–77, 1980
Antonin KH, Bieck P: Gastroscopic evaluation of gastrointestinal effects of diclofenac-sodium and indomethacin administered by continuous intravenous infusion over 24 hours compared to an oral treatment. Gastroenterology 96:A12, 1989 (abstract)
Carson JL, Strom BL, Morse ML, West SL, Soper KA: The relative gastrointestinal toxicity of the non-steroidal antiinflammatory drugs. Arch Intern Med 147:1054–1059, 1987
Adams SS: Non-steroidal anti-inflammatory drugs, plasma half-lives, and adverse reactions. Lancet 2:1204–1205, 1987
Giercksky KE, Husby G, Rugstad HE, Revhaug A: Epidemiology of NSAID-induced gastrointestinal problems and the role of the cimetidine in their prevention. Aliment Pharmacol Ther 2S:33–41, 1988
Butt JH, Barthel JS, Hosokawa MC, Moore RA: NSAIDs: A clinical approach to the problems of gastrointestinal side effects. Aliment Pharmacol Ther 2S:121–129, 1988
Barrier CL, Hirschowitz BI: Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum 32:926–932, 1989
Walt R, Logan R, Katschinski B, Ashley J, Langman M: Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1:489–492, 1986
Hawkey CJ: Non-steroidal anti-inflammatory drugs and peptic ulcers. Br Med J 300:278–284, 1990
Graham DY, Smith JL, Holmes GI: Nonsteroidal antiinflammatory effects of sulindac sulfoxide and sulfide on gastric mucosa. Clin Pharmacol Ther 38:65–70, 1985
Pounder R: Silent peptic ulceration: deadly silence or golden silence? Gastroenterology 96:626–631, 1989
Silvoso GR, Ivey KJ, Butt JH, Lockard OO, Holt SD, Sisk C, Baskin WN, Mackercher PA, Hewett J: Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 91:517–520, 1979
Lanza FL, Royer GL, Nelson RS, Chen TT, Seckman CE, Rack MF: The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers. A gastroscopic and photographic study. Dig Dis Sci 24:823–828, 1979
Lanza F: Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med 13:19–23, 1984
Lanza FL, Royer GL, Nelson RS, Chen TT, Seckman CE, Rack MF: A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J Gastroenterol 75:17–21, 1981
Skander MP, Ryan FP: Non-steroidal anti-inflammatory drugs and pain-free peptic ulceration in the elderly. Br Med J 297:833–834, 1988
Larkai EN, Smith JL, Lidsky MD, Graham DY: Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 82:1153–1158, 1987
Walters LL, Budin RE, Paull G: Acridine-orange to identifyCampylobacter pyloridis in formalin fixed, paraffin-embedded gastric biopsies. Lancet 1:42, 1986
Ciba-Geigy AG: Wissenschaftliche Tabellen Geigy. Basle, Switzerland, 1979
Maggi CA, Lualdi P, Mautone G: Comparative bioavailability of diclofenac hydroxyethylpyrrolidine vs diclofenac sodium in man. Eur J Clin Pharmacol 38:207–208, 1990
Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS: Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs 20:24–48, 1980
Chalmers TC, Berrier J, Hewitt P, Berlin J, Reitman D, Nagalingam R, Sacks H: Meta-analysis of randomized controlled trials as a method of estimating rate complications of non-steroidal anti-inflammatory drug therapy. Aliment Pharmacol Ther 2S:9–26, 1988
Silvoso GR, Ivey KJ, Butt JH, Lockard OO, Holt S: Incidence of gastric lesions in patients with rheumatoid arthritis and osteoarthritis on chronic aspirin therapy. Gastroenterology 74:1094, 1978 (abstract)
Blum AL, Arnold R, Classen M, Goebell H, Fischer M, Witzel L, the RUDER Study Group: RUDER—prospective study of the risk factors for duodenal ulcer healing in 2109 patients. Gastroenterology 96:A47, 1989 (abstract)
Kang JY, Yap I, Guan R, Tay HH: Acid perfusion of duodenal ulcer craters and ulcer pain: A controlled double blind study. Gut 27:942–945, 1986
Rainsford KD, Whitehouse MV: Biochemical gastroprotection from acute ulceration induced by aspirin and related drugs. Biochem Pharmacol 29:1281–1289, 1980
Bowen BK, Krause WJ, Ivey KJ: Effect of sodium bicarbonate on aspirin-induced damage and potential difference changes in human gastric mucosa. Br Med J 2:1052–1055, 1977
Baskin WN, Ivey KJ, Krause WJ, Jeffrey GE, Gemmell RT: Aspirin-induced ultrastructural changes in human gastric mucosa. Correlation with potential difference. Ann Intern Med 85:299–303, 1976
Meyer RA, McGingley D, Posalaky Z: Effects of aspirin on tight junction structure of the canine gastric mucosa. Gastroenterology 91:351–359, 1986
Kitahora T, Guth P: Effects of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology 93:810–817, 1987
Ivey KJ, Paone DB, Krause WJ: Acute effect of systemic aspirin on gastric mucosa in man. Dig Dis Sci 25:97–99, 1980
Garner A, Allen A, Rowe PH: Gastroduodenal mucosal defense mechanisms and the actions of non-steroidal antiinflammatory agents. Scand J Gastroenterol 22(Suppl 127):29–34, 1987
Garner A, Flemström G, Heylings JR: Effects of antiinflammatory agents and prostaglandins on acid and bicarbonate secretions in the amphibian-isolated gastric mucosa. Gastroenterology 77:451–457, 1979
Domschke W, Domschke S, Hornig D: Prostaglandin stimulated gastric mucus secretion in man. Acta Hepato-Gastroenterol 25:292–294, 1978
Rainsford KD: The effects of aspirin and other non-steroidal anti-inflammatory analgesic drugs on gastrointestinal mucus glycoprotein biosynthesisin vivo: Relationship to ulcerogenic actions. Biochem Pharmacol 27:877–885, 1978
Bickel M, Kaufmann GL: Gastric gel mucus thickness: Effect of distention, 16,16-dimethyl prostaglandin E2, and carbenoxolone. Gastroenterology 80:770–775, 1981
Allen A, Garner A: Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut 21:249–262, 1980
Rees WDW, Gibbons LC, Warhurst G, Turnberg LA: Studies of bicarbonate secretion by the normal human stomachin vivo. Effect of aspirin, sodium taurocholate, and prostaglandin E2.In Mechanisms of Gastric Mucosal Protection in the Upper Gastrointestinal Tract. A Allen, G Flemström, A Garner, G Silen, LA Turnberg. (eds). New York: Raven, 1984, pp 119–124
Gerkens JF, Shand DG, Flexner C, Nies AS, Oates J, Data JL: Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Pharmacol Exp Ther 203:646–652, 1977
Hurley JW, Crandall LA: The effect of salicylates upon the stomach of dogs. Gastroenterology 46:36–43, 1974
Wallace JL, Morris GP, Krausse EJ, Greaves SE: Reduction by cytoprotective agents of ethanol-induced damage to the rat gastric mucosa: a correlated morphological and physiological study. Can J Physiol Pharmacol 60:1686–1699, 1982
Levi S, Vesey D, Kaftam S, Hodgson HJF: Indomethacin inhibits the normal regenerative response after experimental gastric ulceration. Gut 30:A1442, 1989 (abstract)
Ciccolunghi SN, Chaudri HA, Schubiger BI: The value and results of long term studies with diclofenac sodium. Rheumatol Rehabil Suppl 2:100–110, 1979
Caldwell JR: Efficacy and safety in diclofenac sodium in rheumatoid arthritis. Experience in the United States. Am J Med 80 (suppl 4B): 43–46, 1986
Dutta SK, Al-Ibrahim MS: Immunological studies in acute pseudomembranous esophageal candidiasis. Gastroenterology 75:292–296, 1978
Jensen KB, Stenderup A, Thomsen JB, Bichel J: Oesophageal moniliasis in malignant neoplastic disease. Acta Med Scand. 175:455–459, 1964
Castillo S, Aburashed A, Kimmelman J, Alexander LC: Diffuse esophageal pseudodiverticulosis. Gastroenterology 72:541–545, 1977
Brühlman WF, Zollikofer CL, Maranta E, Hefti ML, Bivetti J, Giger M, Wellauer J, Blum AL: Intramural pseudodiverticulosis of the esophagus: Report of seven cases and literature review. Gastrointest Radiol 6:199–208, 1981
Shorrock CJ, Prescott RJ, Rees WDW: The effects of indomethacin on gastroduodenal morphology and mucosal pH gradient in the healthy human stomach. Gastroenterology 99:334–339, 1990
McIntyre RLE, Irani MS, Piris J: Histological study of the effects of three anti-inflammatory preparations on the gastric mucosa. J Clin Pathol 34:836–842, 1980
Graham DY, Agrawal NM, Roth SH: Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial. Lancet 2:1277–1280, 1988
Walan A, Bader JP, Classen M, Lamers C, Piper DW, Rutgersson K, Eriksson S: Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 320:69–75, 1989
Manniche C, Malchow-Moller A, Andersen JR: Randomized study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut 28:226–229, 1987
O'Laughlin JC, Silvoso GK, Ivey KJ: Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin: A double-blind study with cimetidine and follow-up. Dig Dis Sci 27:976–980, 1982
Author information
Authors and Affiliations
Additional information
Supported in part by a grant from IBSA, Lugano, Switzerland, and in part by SNF grant 32-26369.89
Rights and permissions
About this article
Cite this article
Stadler, P., Armstrong, D., Margalith, D. et al. Diclofenac delays healing of gastroduodenal mucosal lesions. Digest Dis Sci 36, 594–600 (1991). https://doi.org/10.1007/BF01297025
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01297025